Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)

Market Cap	29.43M -39.6%
Revenue (ttm)	8.02M +45.3%
Net Income	-2.38M
EPS	-0.02
Shares Out	150.93M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,000
Average Volume	210,565
Open	0.1950
Previous Close	n/a
Day's Range	0.1950 - 0.1950
52-Week Range	0.1450 - 0.3000
Beta	-0.11
RSI	48.38
Earnings Date	May 22, 2026

About KLSE:MGRC

Malaysian Genomics Resource Centre Berhad, together with its subsidiaries, provides genetics, genomics, immunotherapy, and biopharmaceutical services worldwide. Its flagship product, Dtect genetic screening tests which inspects DNA for markers associated with genetic variations that influence various biological processes. The company also offers genome sequencing services for humans, animals, plants, and microbes and other living organisms; transcriptome sequencing; and metagenomics and metatranscriptomics. In addition, it provides genome analy...

• Industry: Commercial Physical and Biological Research
• Founded: 2004
• Employees: 16
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: MGRC

Financial Performance

In 2025, KLSE:MGRC's revenue was 8.02 million, an increase of 45.29% compared to the previous year's 5.52 million. Losses were -2.38 million, -43.17% less than in 2024.